Canada Life’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.7M | Buy |
50,296
+2,073
| +4% | +$516K | 0.02% | 473 |
|
|
2025
Q4 | $13.3M | Sell |
48,223
-28,220
| -37% | -$7.72M | 0.02% | 457 |
|
|
2025
Q3 | $19.9M | Sell |
76,443
-24
| -0% | -$5.83K | 0.03% | 430 |
|
|
2025
Q2 | $16.8M | Sell |
76,467
-2,394
| -3% | -$512K | 0.03% | 456 |
|
|
2025
Q1 | $17.7M | Buy |
78,861
+15,049
| +24% | +$4.15M | 0.03% | 436 |
|
|
2024
Q4 | $20.9M | Buy |
63,812
+2,744
| +4% | +$864K | 0.04% | 406 |
|
|
2024
Q3 | $18.4M | Buy |
61,068
+1,108
| +2% | +$339K | 0.03% | 437 |
|
|
2024
Q2 | $19.8M | Buy |
59,960
+4,506
| +8% | +$1.59M | 0.04% | 396 |
|
|
2024
Q1 | $21.9M | Buy |
55,454
+918
| +2% | +$340K | 0.04% | 366 |
|
|
2023
Q4 | $19.1M | Sell |
54,536
-80
| -0.1% | -$28.3K | 0.04% | 383 |
|
|
2023
Q3 | $20.5M | Buy |
54,616
+3,157
| +6% | +$1.22M | 0.05% | 352 |
|
|
2023
Q2 | $19.8M | Sell |
51,459
-8,318
| -14% | -$2.97M | 0.05% | 366 |
|
|
2023
Q1 | $20.7M | Sell |
59,777
-321
| -0.5% | -$93.8K | 0.05% | 360 |
|
|
2022
Q4 | $14.2M | Sell |
60,098
-3,988
| -6% | -$945K | 0.04% | 437 |
|
|
2022
Q3 | $15.8M | Sell |
64,086
-4,486
| -7% | -$1.37M | 0.04% | 396 |
|
|
2022
Q2 | $20.8M | Sell |
68,572
-20,532
| -23% | -$6.68M | 0.05% | 337 |
|
|
2022
Q1 | $38.6M | Buy |
89,104
+1,891
| +2% | +$740K | 0.08% | 253 |
|
|
2021
Q4 | $40.8M | Sell |
87,213
-4,738
| -5% | -$2.04M | 0.08% | 241 |
|
|
2021
Q3 | $39.3M | Buy |
91,951
+1,547
| +2% | +$652K | 0.09% | 240 |
|
|
2021
Q2 | $32.4M | Sell |
90,404
-13,886
| -13% | -$4.59M | 0.07% | 289 |
|
|
2021
Q1 | $29.2M | Sell |
104,290
-4,019
| -4% | -$1.15M | 0.07% | 297 |
|
|
2020
Q4 | $30.6M | Buy |
108,309
+56,569
| +109% | +$15.9M | 0.06% | 324 |
|
|
2020
Q3 | $14.2M | Sell |
51,740
-14
| -0% | -$3.71K | 0.03% | 456 |
|
|
2020
Q2 | $11.7M | Sell |
51,754
-12,088
| -19% | -$2.38M | 0.03% | 478 |
|
|
2020
Q1 | $9.77M | Buy |
63,842
+3,249
| +5% | +$500K | 0.03% | 468 |
|
|
2019
Q4 | $9.04M | Buy |
60,593
+17,067
| +39% | +$2.48M | 0.02% | 585 |
|
|
2019
Q3 | $6.18M | Sell |
43,526
-111
| -0.3% | -$15.3K | 0.01% | 635 |
|
|
2019
Q2 | $5.46M | Sell |
43,637
-1,047
| -2% | -$124K | 0.01% | 704 |
|
|
2019
Q1 | $4.92M | Sell |
44,684
-470
| -1% | -$48.9K | 0.01% | 657 |
|
|
2018
Q4 | $4.11M | Buy |
45,154
+3,724
| +9% | +$404K | 0.01% | 703 |
|
|
2018
Q3 | $5.12M | Sell |
41,430
-823
| -2% | -$92.3K | 0.01% | 690 |
|
|
2018
Q2 | $4.2M | Sell |
42,253
-2,017
| -5% | -$186K | 0.01% | 768 |
|
|
2018
Q1 | $3.91M | Buy |
44,270
+44
| +0.1% | +$4.12K | 0.01% | 786 |
|
|
2017
Q4 | $4.36M | Sell |
44,226
-362
| -0.8% | -$35.5K | 0.01% | 746 |
|
|
2017
Q3 | $4.29M | Buy |
44,588
+969
| +2% | +$87.7K | 0.01% | 745 |
|
|
2017
Q2 | $4.12M | Buy |
43,619
+510
| +1% | +$46.9K | 0.01% | 748 |
|
|
2017
Q1 | $3.52M | Buy |
43,109
+1,718
| +4% | +$144K | 0.01% | 812 |
|
|
2016
Q4 | $3.52M | Sell |
41,391
-2,639
| -6% | -$208K | 0.01% | 807 |
|
|
2016
Q3 | $3.28M | Buy |
44,030
+2,131
| +5% | +$169K | 0.01% | 804 |
|
|
2016
Q2 | $3.18M | Buy |
41,899
+34,698
| +482% | +$2.53M | 0.01% | 805 |
|
|
2016
Q1 | $498K | Hold |
7,201
| – | – | ﹤0.01% | 917 |
|
|
2015
Q4 | $434K | Buy |
7,201
+1,228
| +21% | +$73.9K | ﹤0.01% | 949 |
|
|
2015
Q3 | $324K | Hold |
5,973
| – | – | ﹤0.01% | 1011 |
|
|
2015
Q2 | $346K | Hold |
5,973
| – | – | ﹤0.01% | 1107 |
|
|
2015
Q1 | $358K | Hold |
5,973
| – | – | ﹤0.01% | 1066 |
|
|
2014
Q4 | $317K | Buy |
5,973
+1,399
| +31% | +$70K | ﹤0.01% | 1089 |
|
|
2014
Q3 | $205K | Hold |
4,574
| – | – | ﹤0.01% | 1217 |
|
|
2014
Q2 | $192K | Hold |
4,574
| – | – | ﹤0.01% | 1159 |
|
|
2014
Q1 | $200K | Hold |
4,574
| – | – | ﹤0.01% | 1098 |
|
|
2013
Q4 | $226K | Buy |
+4,574
| New | +$214K | ﹤0.01% | 1045 |
|
Other funds holding WST
VCM
VPM
GIM
Canada Life's WST Position: Q1 2026 in Review
Canada Life increased its West Pharmaceutical (WST) stake by 4.3% in Q1 2026, buying an estimated $516K and bringing the position to 50,296 shares worth $12.7M. The position accounts for 0.02% of the portfolio, ranked #473.
Canada Life first reported a position in WST in Q4 2013 and has held it in 50 quarters since. The position peaked at $40.8M in Q4 2021. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.
- Canada Life held 50,296 shares of West Pharmaceutical worth $12.7M as of Q1 2026.
- Canada Life bought 2,073 West Pharmaceutical shares in Q1 2026, an estimated $516K.
- West Pharmaceutical made up 0.02% of Canada Life's portfolio in Q1 2026, its #473 holding.
- Canada Life first reported a position in West Pharmaceutical in Q4 2013 and has held it in 50 quarters since.
- Canada Life's West Pharmaceutical position peaked at $40.8M in Q4 2021.
- 753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.
Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.